To date, the insertion of SPECC1L gene sequences into e8a2 BCR::ABL1 fusion transcripts has been reported in two CML cases, and the V379I mutation (in ABL1) has been identified in two additional CML cases. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.